Mouse Models to Elucidate the Functional Roles of Adenosine-to-Inosine Editing

Methods in Enzymology

Volumn 424, Issue , 2007, Pages 333-367

  Rula, Elizabeth Y ^a   Emeson, Ronald B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA; DOUBLE STRANDED RNA; INOSINE; UNCLASSIFIED DRUG; ION CHANNEL; POTASSIUM CHANNEL; SEROTONIN 2C RECEPTOR;

CATALYSIS; CATALYST; DEAMINATION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE TARGETING; GENOME; HOMOLOGOUS RECOMBINATION; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA EDITING; RNA SEQUENCE; RNA TRANSCRIPTION; ANIMAL; ARTICLE; CHEMISTRY; CONFORMATION; ENZYME SPECIFICITY; GENETICS; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; TRANSGENIC MOUSE;

MAMMALIA; MUS;

ADENOSINE; ANIMALS; BASE SEQUENCE; INOSINE; ION CHANNELS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEIC ACID CONFORMATION; POTASSIUM CHANNELS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, SEROTONIN, 5-HT2C; RNA EDITING; SUBSTRATE SPECIFICITY;

EID: 34548564602     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)24016-9     Document Type: Chapter

References (118)

1. Athanasiadis A., Rich A., and Maas S. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol. 2 (2004) e391
2. Auerbach W., Dunmore J.H., Fairchild-Huntress V., Fang Q., Auerbach A.B., Huszar D., and Joyner A.L. Establishment and chimera analysis of 129/SvEv- and C57BL/6-derived mouse embryonic stem cell lines. Biotechniques 29 (2000) 1024-1028 1030, 1032
3. Baharvand H., and Matthaei K.I. Culture condition difference for establishment of new embryonic stem cell lines from the C57BL/6 and BALB/c mouse strains. In Vitro Cell. Dev. Biol. Anim. 40 (2004) 76-81
4. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 71 (2002) 817-846
5. Bernard A., and Khrestchatisky M. Assessing the extent of RNA editing in the TMII regions of GluR5 and GluR6 kainate receptors during rat brain development. J. Neurochem. 62 (1994) 2057-2060
6. Bernard A., Ferhat L., Dessi F., Charton G., Represa A., Ben-Ari Y., and Khrestchatisky M. Q/R editing of the rat GluR5 and GluR6 kainate receptors in vivo and in vitro: Evidence for independent developmental, pathological and cellular regulation. Eur. J. Neurosci. 11 (1999) 604-616
7. Bhalla T., Rosenthal J.J., Holmgren M., and Reenan R. Control of human potassium channel inactivation by editing of a small mRNA hairpin. Nat. Struct. Mol. Biol. 11 (2004) 950-956
8. Blow M., Futreal P.A., Wooster R., and Stratton M.R. A survey of RNA editing in human brain. Genome Res. 14 (2004) 2379-2387
9. Borrelli E., Heyman R., Hsi M., and Evans R.M. Targeting of an inducible toxic phenotype in animal cells. Proc. Natl. Acad. Sci. USA 85 (1988) 7572-7576
10. Brocard J., Feil R., Chambon P., and Metzger D. A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor. Nucleic Acids Res. 26 (1998) 4086-4090
11. Brusa R., Zimmermann F., Koh D.S., Feldmeyer D., Gass P., Seeburg P.H., and Sprengel R. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270 (1995) 1677-1680
12. Burd C.G., and Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science 265 (1994) 615-621
13. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E., and Emeson R.B. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387 (1997) 303-308
14. Chen C.X., Cho D.S., Wang Q., Lai F., Carter K.C., and Nishikura K. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 6 (2000) 755-767
15. Cheng J., Dutra A., Takesono A., Garrett-Beal L., and Schwartzberg P.L. Improved generation of C57BL/6J mouse embryonic stem cells in a defined serum-free media. Genesis 39 (2004) 100-104
16. Cho D.S., Yang W., Lee J.T., Shiekhattar R., Murray J.M., and Nishikura K. Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA. J. Biol. Chem. 278 (2003) 17093-17102
17. Collins S.C., Wallis R.H., Wallace K., Bihoreau M.T., and Gauguier D. Marker-assisted congenic screening (MACS): A database tool for the efficient production and characterization of congenic lines. Mamm. Genome 14 (2003) 350-356
18. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., and McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8 (1998) 1323-1326
19. Dawson T.R., Sansam C.L., and Emeson R.B. Structure and sequence determinants required for the RNA editing of ADAR2 substrates. J. Biol. Chem. 279 (2004) 4941-4951
20. Deng C., and Capecchi M.R. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Mol. Cell. Biol. 12 (1992) 3365-3371
21. Dingledine R., Hume R.I., and Heinemann S.F. Structural determinants of barium permeation and rectification in non-NMDA glutamate receptor channels. J. Neurosci. 12 (1992) 4080-4087
22. Dubovsky S.L., and Thomas M. Beyond specificity: Effects of serotonin and serotonergic treatments on psychobiological dysfunction. J. Psychosom. Res. 39 (1995) 429-444
23. Eckmann C.R., Neunteufl A., Pfaffstetter L., and Jantsch M.F. The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein. Mol. Biol. Cell 12 (2001) 1911-1924
24. 2+ permeability of unedited and edited versions of the kainate selective glutamate receptor GluR6. Proc. Natl. Acad. Sci. USA 90 (1993) 755-759
25. Egebjerg J., Kukekov V., and Heinemann S.F. Intron sequence directs RNA editing of the glutamate receptor subunit GluR2 coding sequence. Proc. Natl. Acad. Sci. USA 91 (1994) 10270-10274
26. Emeson R., and Singh M. Adenosine-to-inosine RNA editing: Substrates and consequences. In: Bass B. (Ed). "RNA Editing" (2001), Oxford University Press, Oxford, UK 109-138
27. Feil R., Brocard J., Mascrez B., LeMeur M., Metzger D., and Chambon P. Ligand-activated site-specific recombination in mice. Proc. Natl. Acad. Sci. USA 93 (1996) 10887-10890
28. Feldmeyer D., Kask K., Brusa R., Kornau H.C., Kolhekar R., Rozov A., Burnashev N., Jensen V., Hvalby O., Sprengel R., and Seeburg P.H. Neurological dysfunctions in mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nat. Neurosci. 2 (1999) 57-64
29. Feng Y., Sansam C.L., Singh M., and Emeson R.B. Altered RNA editing in mice lacking ADAR2 autoregulation. Mol. Cell. Biol. 26 (2006) 480-488
30. George C.X., and Samuel C.E. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc. Natl. Acad. Sci. USA 96 (1999) 4621-4626
31. Gerber A., O'Connell M.A., and Keller W. Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA 3 (1997) 453-463
32. Gerber A., Grosjean H., Melcher T., and Keller W. Tad1p, a yeast tRNA-specific adenosine deaminase, is related to the mammalian pre-mRNA editing enzymes ADAR1 and ADAR2. EMBO J. 17 (1998) 4780-4789
33. Gerlai R. Targeting genes and proteins in the analysis of learning and memory: Caveats and future directions. Rev. Neurosci. 11 (2000) 15-26
34. + channel inactivation, spike broadening, and after-hyperpolarization in Kvbeta1.1-deficient mice with impaired learning. Learn. Mem. 5 (1998) 257-273
35. Gossler A., Doetschman T., Korn R., Serfling E., and Kemler R. Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc. Natl. Acad. Sci. USA 83 (1986) 9065-9069
36. Gott J.M., and Emeson R.B. Functions and mechanisms of RNA editing. Annu. Rev. Genet. 34 (2000) 499-531
37. Grigorenko E.V., Bell W.L., Glazier S., Pons T., and Deadwyler S. Editing status at the Q/R site of the GluR2 and GluR6 glutamate receptor subunits in the surgically excised hippocampus of patients with refractory epilepsy. Neuroreport 9 (1998) 2219-2224
38. Hartner J.C., Schmittwolf C., Kispert A., Muller A.M., Higuchi M., and Seeburg P.H. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 279 (2004) 4894-4902
39. Hasty P., Rivera-Perez J., and Bradley A. The length of homology required for gene targeting in embryonic stem cells. Mol. Cell. Biol. 11 (1991) 5586-5591
40. Herbert A. RNA editing, introns and evolution. Trends Genet. 12 (1996) 6-9
41. Herson P.S., Virk M., Rustay N.R., Bond C.T., Crabbe J.C., Adelman J.P., and Maylie J. A mouse model of episodic ataxia type-1. Nat. Neurosci. 6 (2003) 378-383
42. Higuchi M., Single F.N., Kohler M., Sommer B., Sprengel R., and Seeburg P.H. RNA editing of AMPA receptor subunit GluR-B: A base-paired intron-exon structure determines position and efficiency. Cell 75 (1993) 1361-1370
43. Higuchi M., Maas S., Single F.N., Hartner J., Rozov A., Burnashev N., Feldmeyer D., Sprengel R., and Seeburg P.H. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406 (2000) 78-81
44. Hoess R.H., and Abremski K. Interaction of the bacteriophage P1 recombinase Cre with the recombining site loxP. Proc. Natl. Acad. Sci. USA 81 (1984) 1026-1029
45. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252 (1991) 851-853
46. Hoopengardner B., Bhalla T., Staber C., and Reenan R. Nervous system targets of RNA editing identified by comparative genomics. Science 301 (2003) 832-836
47. Hough R.F., and Bass B.L. Purification of the Xenopus laevis double-stranded RNA adenosine deaminase. J. Biol. Chem. 269 (1994) 9933-9939
48. Hough R.F., and Bass B.L. Analysis of Xenopus dsRNA adenosine deaminase cDNAs reveals similarities to DNA methyltransferases. RNA 3 (1997) 356-370
49. Hough R., and Bass B. Adenosine deaminases that act on RNA. In: Bass B. (Ed). "Frontiers in Molecular Biology" (2001), Oxford University Press, Oxford, UK 77-108
50. Kask K., Zamanillo D., Rozov A., Burnashev N., Sprengel R., and Seeburg P.H. The AMPA receptor subunit GluR-B in its Q/R site-unedited form is not essential for brain development and function. Proc. Natl. Acad. Sci. USA 95 (1998) 13777-13782
51. Kellendonk C., Tronche F., Monaghan A.P., Angrand P.O., Stewart F., and Schutz G. Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res. 24 (1996) 1404-1411
52. Kikuno R., Nagase T., Waki M., and Ohara O. HUGE: A database for human large proteins identified in the Kazusa cDNA sequencing project. Nucleic Acids Res. 30 (2002) 166-168
53. Kim D.D., Kim T.T., Walsh T., Kobayashi Y., Matise T.C., Buyske S., and Gabriel A. Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res. 14 (2004) 1719-1725
54. Kim U., Garner T.L., Sanford T., Speicher D., Murray J.M., and Nishikura K. Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts. J. Biol. Chem. 269 (1994) 13480-13489
55. Kim U., Wang Y., Sanford T., Zeng Y., and Nishikura K. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl. Acad. Sci. USA 91 (1994) 11457-11461
56. 2+ permeability in both TM1 and TM2 of high affinity kainate receptor channels: Diversity by RNA editing. Neuron 10 (1993) 491-500
57. Koller B.H., and Smithies O. Altering genes in animals by gene targeting. Annu. Rev. Immunol. 10 (1992) 705-730
58. Lai F., Drakas R., and Nishikura K. Mutagenic analysis of double-stranded RNA adenosine deaminase, a candidate enzyme for RNA editing of glutamate-gated ion channel transcripts. J. Biol. Chem. 270 (1995) 17098-17105
59. Lai F., Chen C.X., Carter K.C., and Nishikura K. Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases. Mol. Cell. Biol. 17 (1997) 2413-2424
60. Lakso M., Pichel J.G., Gorman J.R., Sauer B., Okamoto Y., Lee E., Alt F.W., and Westphal H. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93 (1996) 5860-5865
61. Lehmann K.A., and Bass B.L. The importance of internal loops within RNA substrates of ADAR1. J. Mol. Biol. 291 (1999) 1-13
62. Lehmann K.A., and Bass B.L. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 39 (2000) 12875-12884
63. Levanon E.Y., Eisenberg E., Yelin R., Nemzer S., Hallegger M., Shemesh R., Fligelman Z.Y., Shoshan A., Pollock S.R., Sztybel D., Olshansky M., Rechavi G., and Jantsch M.F. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 22 (2004) 1001-1005
64. Liu Y., George C.X., Patterson J.B., and Samuel C.E. Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase. J. Biol. Chem. 272 (1997) 4419-4428
65. Lomeli H., Mosbacher J., Melcher T., Hoger T., Geiger J.R., Kuner T., Monyer H., Higuchi M., Bach A., and Seeburg P.H. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266 (1994) 1709-1713
66. Maas S., Melcher T., Herb A., Seeburg P.H., Keller W., Krause S., Higuchi M., and O'Connell M.A. Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase. J. Biol. Chem. 271 (1996) 12221-12226
67. Madden D.R. The inner workings of the AMPA receptors. Curr. Opin. Drug Discov. Dev. 5 (2002) 741-748
68. Melcher T., Maas S., Higuchi M., Keller W., and Seeburg P.H. Editing of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor GluR-B pre-mRNA in vitro reveals site-selective adenosine to inosine conversion. J. Biol. Chem. 270 (1995) 8566-8570
69. Melcher T., Maas S., Herb A., Sprengel R., Higuchi M., and Seeburg P.H. RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J. Biol. Chem. 271 (1996) 31795-31798
70. Melcher T., Maas S., Herb A., Sprengel R., Seeburg P.H., and Higuchi M. A ssmammalian RNA editing enzyme. Nature 379 (1996) 460-464
71. Misra R.P., and Duncan S.A. Gene targeting in the mouse: Advances in introduction of transgenes into the genome by homologous recombination. Endocrine 19 (2002) 229-238
72. Morse D.P., and Bass B.L. Long RNA hairpins that contain inosine are present in Caenorhabditis elegans poly(A)+ RNA. Proc. Natl. Acad. Sci. USA 96 (1999) 6048-6053
73. Morse D.P., Aruscavage P.J., and Bass B.L. RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA. Proc. Natl. Acad. Sci. USA 99 (2002) 7906-7911
74. Nagy A., Gertsenstein M., Vintersten K., and Behringer R. "Manipulating the Mouse Embryo: A Laboratory Manual." (2003), Cold Spring Laboratory Press, Woodbury, NY
75. Niswender C.M., Sanders-Bush E., and Emeson R.B. Identification and characterization of RNA editing events within the 5-HT2C receptor. Ann. N.Y. Acad. Sci. 861 (1998) 38-48
76. Niswender C.M., Copeland S.C., Herrick-Davis K., Emeson R.B., and Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J. Biol. Chem. 274 (1999) 9472-9478
77. O'Connell M.A., and Keller W. Purification and properties of double-stranded RNA-specific adenosine deaminase from calf thymus. Proc. Natl. Acad. Sci. USA 91 (1994) 10596-10600
78. O'Connell M.A., Krause S., Higuchi M., Hsuan J.J., Totty N.F., Jenny A., and Keller W. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol. Cell. Biol. 15 (1995) 1389-1397
79. O'Gorman S., Dagenais N.A., Qian M., and Marchuk Y. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl. Acad. Sci. USA 94 (1997) 14602-14607
80. O'Grady S.M., and Lee S.Y. Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. Int. J. Biochem. Cell Biol. 37 (2005) 1578-1594
81. Ozawa S., Kamiya H., and Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog. Neurobiol. 54 (1998) 581-618
82. Pandey S.C., Davis J.M., and Pandey G.N. Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates. J. Psychiatry Neurosci. 20 (1995) 215-225
83. Pham C.T., MacIvor D.M., Hug B.A., Heusel J.W., and Ley T.J. Long-range disruption of gene expression by a selectable marker cassette. Proc. Natl. Acad. Sci. USA 93 (1996) 13090-13095
84. Pin J.P., Joly C., Heinemann S.F., and Bockaert J. Domains involved in the specificity of G protein activation in phospholipase C-coupled metabotropic glutamate receptors. EMBO J. 13 (1994) 342-348
85. Polson A.G., and Bass B.L. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. EMBO J. 13 (1994) 5701-5711
86. Polson A.G., Crain P.F., Pomerantz S.C., McCloskey J.A., and Bass B.L. The mechanism of adenosine to inosine conversion by the double-stranded RNA unwinding/modifying activity: A high-performance liquid chromatography-mass spectrometry analysis. Biochemistry 30 (1991) 11507-11514
87. Robertson E.J. Using embryonic stem cells to introduce mutations into the mouse germ line. Biol. Reprod. 44 (1991) 238-245
88. Rubsam L.Z., Davidson B.L., and Shewach D.S. Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: A novel paradigm for cell killing. Cancer Res. 58 (1998) 3873-3882
89. Rueter S., and Emeson R. Adenosine-to-inosine conversion in mRNA. In: Grosjean H., and Benne R. (Eds). "Modification and Editing of RNA" (1998), ASM Press, Washington, DC 343-361
90. Rueter S.M., Burns C.M., Coode S.A., Mookherjee P., and Emeson R.B. Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine. Science 267 (1995) 1491-1494
91. Rueter S.M., Dawson T.R., and Emeson R.B. Regulation of alternative splicing by RNA editing. Nature 399 (1999) 75-80
92. Sailer A., Swanson G.T., Perez-Otano I., O'Leary L., Malkmus S.A., Dyck R.H., Dickinson-Anson H., Schiffer H.H., Maron C., Yaksh T.L., Gage F.H., O'Gorman S., and Heinemann S.F. Generation and analysis of GluR5(Q636R) kainate receptor mutant mice. J. Neurosci. 19 (1999) 8757-8764
93. Sauer B., and Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85 (1988) 5166-5170
94. Schaft J., Ashery-Padan R., van der Hoeven F., Gruss P., and Stewart A.F. Efficient FLP recombination in mouse ES cells and oocytes. Genesis 31 (2001) 6-10
95. Schaub M., and Keller W. RNA editing by adenosine deaminases generates RNA and protein diversity. Biochimie 84 (2002) 791-803
96. Schwenk F., Baron U., and Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23 (1995) 5080-5081
97. Seong E., Saunders T.L., Stewart C.L., and Burmeister M. To knockout in 129 or in C57BL/6: That is the question. Trends Genet. 20 (2004) 59-62
98. Shulman M.J., Nissen L., and Collins C. Homologous recombination in hybridoma cells: Dependence on time and fragment length. Mol. Cell. Biol. 10 (1990) 4466-4472
99. Simpson E.M., Linder C.C., Sargent E.E., Davisson M.T., Mobraaten L.E., and Sharp J.J. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat. Genet. 16 (1997) 19-27
100. Sommer B., Kohler M., Sprengel R., and Seeburg P.H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67 (1991) 11-19
101. te Riele H., Maandag E.R., and Berns A. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. Natl. Acad. Sci. USA 89 (1992) 5128-5132
102. Thomas K.R., and Capecchi M.R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51 (1987) 503-512
103. Threadgill D.W., Yee D., Matin A., Nadeau J.H., and Magnuson T. Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm. Genome 8 (1997) 390-393
104. Tohda M., Nomura M., and Nomura Y. Molecular pathopharmacology of 5-HT2C receptors and the RNA editing in the brain. J. Pharmacol. Sci. 100 (2006) 427-432
105. Tucker K.L., Wang Y., Dausman J., and Jaenisch R. A transgenic mouse strain expressing four drug-selectable marker genes. Nucleic Acids Res. 25 (1997) 3745-3746
106. Van Oekelen D., Luyten W.H., and Leysen J.E. 5-HT2A and 5-HT2C receptors and their atypical regulation properties. Life Sci. 72 (2003) 2429-2449
107. Verdoorn T.A., Burnashev N., Monyer H., Seeburg P.H., and Sakmann B. Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252 (1991) 1715-1718
108. Visscher P.M. Speed congenics: Accelerated genome recovery using genetic markers. Genet. Res. 74 (1999) 81-85
109. Vissel B., Royle G.A., Christie B.R., Schiffer H.H., Ghetti A., Tritto T., Perez-Otano I., Radcliffe R.A., Seamans J., Sejnowski T., Wehner J.M., Collins A.C., et al. The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron 29 (2001) 217-227
110. Wagner R.W., Yoo C., Wrabetz L., Kamholz J., Buchhalter J., Hassan N.F., Khalili K., Kim S.U., Perussia B., McMorris F.A., and Nishikura K. Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines. Mol. Cell. Biol. 10 (1990) 5586-5590
111. Wang Q., Khillan J., Gadue P., and Nishikura K. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290 (2000) 1765-1768
112. Wang Q., O'Brien P.J., Chen C.X., Cho D.S., Murray J.M., and Nishikura K. Altered G protein-coupling functions of RNA editing isoform and splicing variant serotonin2C receptors. J. Neurochem. 74 (2000) 1290-1300
113. Wang Q., Miyakoda M., Yang W., Khillan J., Stachura D.L., Weiss M.J., and Nishikura K. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J. Biol. Chem. 279 (2004) 4952-4961
114. Wigler M., Silverstein S., Lee L.S., Pellicer A., Cheng Y., and Axel R. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11 (1977) 223-232
115. Wong G.T. Speed congenics: Applications for transgenic and knock-out mouse strains. Neuropeptides 36 (2002) 230-236
116. Yanagawa Y., Kobayashi T., Ohnishi M., Kobayashi T., Tamura S., Tsuzuki T., Sanbo M., Yagi T., Tashiro F., and Miyazaki J. Enrichment and efficient screening of ES cells containing a targeted mutation: The use of DT-A gene with the polyadenylation signal as a negative selection maker. Transgenic Res. 8 (1999) 215-221
117. Yang J.H., Sklar P., Axel R., and Maniatis T. Editing of glutamate receptor subunit B pre-mRNA in vitro by site-specific deamination of adenosine. Nature 374 (1995) 77-81
118. Zhou M., Morais-Cabral J.H., Mann S., and MacKinnon R. Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature 411 (2001) 657-661